Dr Nicholas Medland

Chidwick K; Pollack A; Busingye D; Norman S; Grulich A; Bavinton B; Guy R; Medland N, 2022, 'Utilisation of pre-exposure prophylaxis (PrEP) for HIV prevention in the Australian general practice setting: A longitudinal observational study', Sexual Health, http://dx.doi.org/10.1071/SH21207

Wells N; Philpot SP; Murphy D; Ellard J; Howard C; Rule J; Fairley C; Prestage G; Brown G; Jin J; Kaldor J; Guy R; Grulich A; Mao L; Donovan B; Persson A; Medland N; Clifton B; Hilton P; Hammoud M; Malhotra S; Bastian L, 2022, 'Belonging, social connection and non-clinical care: Experiences of HIV peer support among recently diagnosed people living with HIV in Australia', Health and Social Care in the Community, http://dx.doi.org/10.1111/hsc.13886

Wells N; Prestage G; Murphy D; Medland N; Mao L; Howard C; Fairley C; Brown G; Philpot SP, 2022, 'Patient-centred approaches to providing care at HIV diagnosis: perspectives from healthcare and peer-support workers', Sexual Health, http://dx.doi.org/10.1071/sh22052

Medland NA; Taylor R; Saunders J; Rayment M; Fox A; Sullivan A, 2022, 'Why sexual health clinics are important in the 2020s', Sexual Health, http://dx.doi.org/10.1071/sh22078

Doyle JS; van Santen DK; Iser D; Sasadeusz J; O'Reilly M; Harney B; Traeger MW; Roney J; Cutts JC; Bowring AL; Winter R; Medland N; Fairley CK; Moore R; Tee BK; Asselin J; El-Hayek C; Hoy JF; Matthews GV; Prins M; Stoové MA; Hellard ME, 2021, 'Microelimination of Hepatitis C Among People With Human Immunodeficiency Virus Coinfection: Declining Incidence and Prevalence Accompanying a Multicenter Treatment Scale-up Trial', Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, vol. 73, pp. e2164 - e2172, http://dx.doi.org/10.1093/cid/ciaa1500

Matthews G, 2021, 'Microelimination of Hepatitis C Among People With Human Immunodeficiency Virus Coinfection: Declining Incidence and Prevalence Accompanying a Multicenter Treatment Scale-up Trial', Clinical Infectious Diseases, http://dx.doi.org/10.1093/cid/ciaa1500

Bao Y; Medland NA; Fairley CK; Wu J; Shang X; Chow EPF; Xu X; Ge Z; Zhuang X; Zhang L, 2021, 'Predicting the diagnosis of HIV and sexually transmitted infections among men who have sex with men using machine learning approaches', Journal of Infection, vol. 82, pp. 48 - 59, http://dx.doi.org/10.1016/j.jinf.2020.11.007

Van Santen DK; Agius PA; Sasadeusz J; Fairley CK; Sievert W; Gane E; Iser D; O'Reilly M; Medland NA; Moore R; Hellard ME; Hoy JF; Doyle JS, 2020, 'The Impact of Markers of HIV Infection on Change in Liver Stiffness in People with HIV and Hepatitis C Virus Co-infection after Treatment and Cure of Hepatitis C', Journal of Acquired Immune Deficiency Syndromes, vol. 85, pp. E81 - E89, http://dx.doi.org/10.1097/QAI.0000000000002487

Su S; Fairley CK; Mao L; Medland N; Shen M; Li Y; Zhuang G; Zhang L, 2020, 'Estimation of the impact of changing drug-use trend on HIV, hepatitis C and syphilis epidemics among people who use synthetic drug-only, polydrug and heroin-only during 2005-2035 in China: Modelling study', Sexually Transmitted Infections, vol. 96, pp. 608 - 614, http://dx.doi.org/10.1136/sextrans-2019-054360

Medland NA; Grulich AE, 2020, 'Hiv diagnoses in australia fall as clinicians embrace pre-exposure prophylaxis', Australian Prescriber, vol. 43, pp. 182 - 183, http://dx.doi.org/10.18773/austprescr.2020.048

Phillips TR; Medland N; Chow EPF; Maddaford K; Wigan R; Fairley CK; Ong JJ; Bilardi JE, 2020, '“Moving from one environment to another, it doesn’t automatically change everything”. Exploring the transnational experience of Asian-born gay and bisexual men who have sex with men newly arrived in Australia', PLoS ONE, vol. 15, http://dx.doi.org/10.1371/journal.pone.0242788

Medland NA; Banys P; Baton VP; Nadela J; Maher L; Tac-An I, 2020, 'Responding to expanding HIV epidemics in Cebu, Philippines', The Lancet HIV, vol. 7, pp. e380 - e381, http://dx.doi.org/10.1016/S2352-3018(19)30405-9

Medland N, 2020, 'Genomics against gonorrhoea', eLife, vol. 9, pp. 1 - 3, http://dx.doi.org/10.7554/eLife.59379

De Oliveira Costa J; Schaffer AL; Medland NA; Litchfield M; Narayan SW; Guy R; McManus H; Pearson SA, 2020, 'Adherence to Antiretroviral Regimens in Australia: A Nationwide Cohort Study', AIDS Patient Care and STDs, vol. 34, pp. 81 - 91, http://dx.doi.org/10.1089/apc.2019.0278

Zhang L; Zou X; Xu Y; Medland N; Deng L; Liu Y; Su S; Ling L, 2019, 'The Decade-Long Chinese Methadone Maintenance Therapy Yields Large Population and Economic Benefits for Drug Users in Reducing Harm, HIV and HCV Disease Burden', Frontiers in Public Health, vol. 7, http://dx.doi.org/10.3389/fpubh.2019.00327

Blackshaw LCD; Chow EPF; Varma R; Healey L; Templeton DJ; Basu A; Turner D; Medland NA; Rix S; Fairley CK; Chen MY, 2019, 'Characteristics of recently arrived Asian men who have sex with men diagnosed with HIV through sexual health services in Melbourne and Sydney', Australian and New Zealand Journal of Public Health, vol. 43, pp. 424 - 428, http://dx.doi.org/10.1111/1753-6405.12926

Medland NA; Chibo D; Chow EPF; Guy RJ; Fairley CK, 2019, 'Is differential access to prevention distorting HIV epidemiology in Australia?', The Lancet HIV, vol. 6, pp. e492, http://dx.doi.org/10.1016/S2352-3018(19)30225-5

Su S; Fairley CK; Mao L; Medland NA; Jing J; Cheng F; Zhang L, 2019, 'Estimates of the national trend of drugs use during 2000–2030 in China: A population-based mathematical model', Addictive Behaviors, vol. 93, pp. 65 - 71, http://dx.doi.org/10.1016/j.addbeh.2019.01.022

McManus H; Callander D; Donovan B; Russell DB; O'Connor CC; Davies SC; Lewis DA; Hellard ME; Chen MY; Petoumenos K; Varma R; Cogle A; Boyd MA; Grulich A; Pollard J; Medland N; Fairley CK; Guy RJ, 2019, 'Early initiation of antiretroviral therapy for people newly diagnosed with HIV infection in Australia: trends and predictors, 2004–2015', Medical Journal of Australia, vol. 210, pp. 269 - 275, http://dx.doi.org/10.5694/mja2.50006

Gunaratnam P; Heywood AE; McGregor S; Jamil MS; McManus H; Mao L; Lobo R; Brown G; Hellard M; Marukutira T; Bretaña NA; Lang C; Medland N; Bavinton B; Grulich A; Guy R, 2019, 'HIV diagnoses in migrant populations in Australia—A changing epidemiology', PLoS ONE, vol. 14, http://dx.doi.org/10.1371/journal.pone.0212268

Santen DV; Hoy J; Agius P; Iser D; O'reilly M; Sasadeusz J; Stoove M; Roney J; Moore R; Bk T; Medland N; Fairley C; Gane E; Matthews G; Prins M; Hellard M; Doyle J, 2019, 'THU-098-Changes in liver stiffness measurements following DAA treatment among HIV/HCV-coinfected individuals: Does HIV contribute to liver disease after HCV cure?', Journal of Hepatology, vol. 70, pp. e204 - e204, http://dx.doi.org/10.1016/s0618-8278(19)30379-2

Chow EPF; Medland NA; Denham I; Wright EJ; Fairley CK, 2018, 'Decline in new HIV diagnoses among MSM in Melbourne', The Lancet HIV, vol. 5, pp. e479 - e481, http://dx.doi.org/10.1016/S2352-3018(18)30217-0

Medland NA; Chow EPF; Read THR; Ong JJ; Chen M; Denham I; Gunaratnum P; Fairley CK, 2018, 'Incident HIV infection has fallen rapidly in men who have sex with men in Melbourne, Australia (2013-2017) but not in the newly-arrived Asian-born', BMC Infectious Diseases, vol. 18, http://dx.doi.org/10.1186/s12879-018-3325-0

Gunaratnam P; McManus H; Watchirs-Smith L; McGregor S; Callander D; Brown G; Lobo R; O'Connor C; Hellard M; Medland N; Lewis D; Palmer C; Law M; Gray R; Donovan B; Guy R, 2018, 'People Born in Non-Main English Speaking Countries Are Less Likely to Start HIV Treatment Early in Australia: A National Cohort Analysis, 2014-15', Journal of Acquired Immune Deficiency Syndromes, vol. 77, pp. E31 - E34, http://dx.doi.org/10.1097/QAI.0000000000001585

Medland NA; Chow EPF; Walker RG; Chen M; Read TRH; Fairley CK, 2018, 'Incidence of renal Fanconi syndrome in patients taking antiretroviral therapy including tenofovir disoproxil fumarate', International Journal of STD and AIDS, vol. 29, pp. 227 - 236, http://dx.doi.org/10.1177/0956462417722133

Jamil MS; McManus H; Callander D; Prestage G; Ali H; O’Connor CC; Chen M; McNulty AM; Knight V; Duck T; Keen P; Gray J; Medland N; Hellard M; Lewis DA; Grulich AE; Kaldor JM; Fairley CK; Donovan B; Guy RJ; Marshall L; Wilson D; Dickson B; Kong M; Smith LW; Cooper D; Selvey C; Holden J; Crooks L; Cooper C; Price K; de Wit J; Kelleher A; Mitchell J; Schmidt HM; Telfer B; Whittaker B, 2018, 'Understanding the Targeting and Uptake of HIV Testing Among Gay and Bisexual Men Attending Sexual Health Clinics', AIDS and Behavior, vol. 22, pp. 513 - 521, http://dx.doi.org/10.1007/s10461-017-2012-2

Read TRH; Walker S; Chow EPF; Ong JJ; Bradshaw CS; Medland NA; Wigan R; Chen MY; Fairley CK, 2018, 'HIV testing with and without a clinical consultation among men who have sex with men: A randomized controlled trial', Journal of Acquired Immune Deficiency Syndromes, vol. 78, pp. 406 - 412, http://dx.doi.org/10.1097/QAI.0000000000001688

Medland NA; Nicholson S; Chow EPF; Read TRH; Bradshaw CS; Denham I; Fairley CK, 2017, 'Time from HIV infection to virological suppression: Dramatic fall from 2007 to 2016', AIDS, vol. 31, pp. 2377 - 2385, http://dx.doi.org/10.1097/QAD.0000000000001634

Medland NA; Chow EPF; McMahon JH; Elliott JH; Hoy JF; Fairley CK, 2017, 'Time from HIV diagnosis to commencement of antiretroviral therapy as an indicator to supplement the HIV cascade: Dramatic fall from 2011 to 2015', PLoS ONE, vol. 12, http://dx.doi.org/10.1371/journal.pone.0177634

Medland NA; Chow EPF; Bradshaw CS; Read THR; Sasadeusz JJ; Fairley CK, 2017, 'Predictors and incidence of sexually transmitted Hepatitis C virus infection in HIV positive men who have sex with men', BMC Infectious Diseases, vol. 17, http://dx.doi.org/10.1186/s12879-017-2288-x

Doyle JS; Bowring AL; Cutts J; Roney J; Iser DM; Sasadeusz J; O’Reilly M; Fairley C; Gane E; Hoy J; Matthews GV; Medland N; Moore R; Prins M; Stoové M; Tee BK; Hellard ME, 2017, 'O5 Hepatitis C elimination in HIV/HCV co-infection through HCV treatment in primary care is feasible and highly effective', Journal of Virus Eradication, vol. 3, pp. 2 - 2, http://dx.doi.org/10.1016/s2055-6640(20)30888-8

Medland NA; Mao L; Crooks L; de Wit J, 2016, 'Obstacles to prescribers' initiation early antiretroviral therapy: a barrier to achieving 90-90-90 goals', The Lancet HIV, vol. 3, pp. e559 - e560, http://dx.doi.org/10.1016/S2352-3018(16)30172-2

Klassen KM; Kimlin MG; Fairley CK; Emery S; Anderson PH; Ebeling PR, 2016, 'Associations between vitamin D metabolites, antiretroviral therapy and bone mineral density in people with HIV', Osteoporosis International, vol. 27, pp. 1737 - 1745, http://dx.doi.org/10.1007/s00198-015-3432-3

Medland NA; McMahon JH; Chow EPF; Elliott JH; Hoy JF; Fairley CK, 2015, 'The HIV care cascade: A systematic review of data sources, methodology and comparability', Journal of the International AIDS Society, vol. 18, http://dx.doi.org/10.7448/IAS.18.1.20634

McMahon JH; Moore R; Eu B; Tee BK; Chen M; El-Hayek C; Street A; Woolley I; Buggie A; Collins D; Medland N; Hoy J, 2015, 'Clinic network collaboration and patient tracing to maximize retention in HIV care', PLoS ONE, vol. 10, http://dx.doi.org/10.1371/journal.pone.0127726

Mocroft A; Lundgren JD; Ross M; Law M; Reiss P; Kirk O; Smith C; Wentworth D; Neuhaus J; Fux CA; Moranne O; Morlat P; Johnson MA; Ryom L; Powderly B; Shortman N; Moecklinghoff C; Reilly G; Franquet X; Sabin CA; Phillips A; Weber R; Pradier C; d'Arminio Monforte A; Dabis F; El-Sadr WM; De Wit S; Kamara D; Tverland J; Mansfeld M; Nielsen J; Raben D; Salbøl Brandt R; Rickenbach M; Fanti I; Krum E; Hillebregt M; Geffard S; Sundström A; Delforge M; Fontas E; Torres F; McManus H; Wright S; Kjær J; Sjøl A; Meidahl P; Helweg-Larsen J; Schmidt Iversen J; Kesselring AM; Friis-Møller N; Kowalska J; Sabin C; Bruyand M; Bower M; Fätkenheuer G; Donald A; Grulich A; Prins JM; Kuijpers TW; Scherpbier HJ; van der Meer JTM; Wit FWMN; Godfried MH; van der Poll T; Nellen FJB; Geerlings SE; van Vugt M; Pajkrt D; Bos JC; Wiersinga WJ; van der Valk M; Goorhuis A; Hovius JW; van Eden J; Henderiks A; van Hes AMH; Mutschelknauss M; Nobel HE; Pijnappel FJJ; Westerman AM; Jurriaans S; Back NKT; Zaaijer HL; Berkhout B; Cornelissen MTE; Schinkel CJ; Thomas XV; van den Berge M; Stegeman A; Baas S; Hage de Looff L; Versteeg D; Pronk MJH; Ammerlaan HSM; Korsten-Vorstermans EMHM; de Munnik ES; Jansz AR; Tjhie J, 2015, 'Development and Validation of a Risk Score for Chronic Kidney Disease in HIV Infection Using Prospective Cohort Data from the D:A:D Study', PLoS Medicine, vol. 12, http://dx.doi.org/10.1371/journal.pmed.1001809

Nordell AD; McKenna M; Borges AH; Duprez D; Neuhaus J; Neaton JD, 2014, 'Severity of Cardiovascular Disease Outcomes Among Patients With HIV Is Related to Markers of Inflammation and Coagulation', JOURNAL OF THE AMERICAN HEART ASSOCIATION, vol. 3, http://dx.doi.org/10.1161/JAHA.114.000844

Haskelberg H; Pocock N; Amin J; Ebeling PR; Emery S; Carr A, 2014, 'Hip structural parameters over 96 weeks in HIV-infected adults switching treatment to tenofovir-emtricitabine or abacavir-lamivudine', PLoS ONE, vol. 9, http://dx.doi.org/10.1371/journal.pone.0094858

Borges AH; O'Connor JL; Phillips AN; Baker JV; Vjecha MJ; Losso MH; Klinker H; Lopardo G; Williams I; Lundgren JD, 2014, 'Factors associated with D-dimer levels in HIV-infected individuals', PLoS ONE, vol. 9, http://dx.doi.org/10.1371/journal.pone.0090978

McMahon JH; Medland N, 2014, '90-90-90: How do we get there?', The Lancet HIV, vol. 1, pp. e10 - e11, http://dx.doi.org/10.1016/S2352-3018(14)70017-7

Nguyen DB; Do NT; Shiraishi RW; Le YN; Tran QH; Huu Nguyen H; Medland N; Nguyen LT; Struminger BB, 2013, 'Outcomes of Antiretroviral Therapy in Vietnam: Results from a National Evaluation', PLoS ONE, vol. 8, http://dx.doi.org/10.1371/journal.pone.0055750

Zetterberg E; Neuhaus J; Baker JV; Somboonwit C; Llibre JM; Palfreeman A; Chini M; Lundgren JD, 2013, 'Platelet count kinetics following interruption of antiretroviral treatment', AIDS, vol. 27, pp. 59 - 68, http://dx.doi.org/10.1097/QAD.0b013e32835a104d

Bjerk SM; Baker J; Emery S; Neuhaus JA; Angus BJ; Gordin F; Pett SL; Stephan C; Kunisaki KM, 2013, 'Biomarkers and Bacterial Pneumonia Risk in Patients with Treated HIV Infection: A Case-Control Study', PLoS ONE, vol. 8, pp. e56249, http://dx.doi.org/10.1371/journal.pone.0056249

Cordery D; Martin A; Kelleher AD; Emery S; Cooper DA, 2012, 'The influence of HLA supertype on thymidine analogue associated with low peripheral fat in HIV.', AIDS, vol. 26, pp. 2337 - 2344, http://dx.doi.org/10.1097/QAD.0b013e32835ab213

Haskelberg H; Hoy J; Amin J; Ebeling PR; Emery S; Carr AD, 2012, 'Changes in Bone Turnover and Bone Loss in HIV-Infected Patients Changing Treatment to Tenofovir-Emtricitabine or Abacavir-Lamivudine', PLoS ONE, vol. 7, pp. e38377, http://dx.doi.org/10.1371/journal.pone.0038377

Martin A; Amin J; Emery S; Baker D; Carr AD; Cooper DA; Bloch M, 2011, 'Predictors of limb fat gain in HIV positive patients following a change to tenofovir-emtricitabine or Abacavir-Lamivudine', PLoS One, vol. 6, pp. Article number e26885, http://dx.doi.org/10.1371/journal.pone.0026885

Pett SL; Carey C; Lin E; Wentworth D; Lazovski J; Miro J; Gordin F; Angus B; Rodriguez-Barradas M; Rubio R; Tambussi G; Cooper DA; Emery S, 2011, 'Predictors of bacterial pneumonia in Evaluation of Subcutaneous Interleukin-2 in a Randomized International Trial (ESPRIT)', HIV Medicine, vol. 12, pp. 219 - 227, http://dx.doi.org/10.1111/j.1468-1293.2010.00875.x

Martin A; Amin J; Cooper DA; Carr AD; Kelleher AD; Bloch M; Baker D; Woolley I; Emery S, 2010, 'Abacavir does not affect circulating levels of inflammatory or coagulopathic biomarkers in suppressed HIV: a randomized clinical trial', AIDS, vol. 24, pp. 2657 - 2663, http://dx.doi.org/10.1097/QAD.0b013e32833f147f

Martinez E; Visnegarwala F; Grund B; Thomas A; Gibert C; Shlay J; Drummond F; Pearce D; Edwards S; Reiss P; El-Sadr W; Carr AD, 2010, 'The effects of intermittent, CD4-guided antiretroviral therapy on body composition and metabolic parameters', AIDS, vol. 24, pp. 353 - 363, http://dx.doi.org/10.1097/QAD.0b013e3283333666

Mocroft A; Wyatt C; Szczech L; Neuhaus J; El-Sadr W; Tracy R; Kuller L; Shlipak M; Angus B; Klinker H; Ross M, 2009, 'Interruption of antiretroviral therapy is associated with increased plasma cystatin C', AIDS, vol. 23, pp. 71 - 82, http://dx.doi.org/10.1097/QAD.0b013e32831cc129

Grund B; Peng G; Gibert C; Hoy JF; Isaksson R; Shlay J; Martinez E; Reiss P; Visnegarwala F; Carr AD, 2009, 'Continuous antiretroviral therapy decreases bone mineral density', AIDS, vol. 23, pp. 1519 - 1529, http://dx.doi.org/10.1097/QAD.0b013e32832c1792

Abrams A; Levy Y; Losso MH; Babiker AG; Collins G; Cooper DA; Darbyshire JH; Emery S; Fox L; Gordin F; Lane HC; Lundgren JD; Mitsuyasu R; Neaton J; Phillips AN; Routy J; Tambussi G; Wentworth D, 2009, 'Interleukin-2 therapy in patients with HIV infection.', New England Journal of Medicine, vol. 361, pp. 1548 - 1559, http://dx.doi.org/10.1056/NEJMoa0903175

Rodger A; Fox Z; Lundgren JD; Kuller LH; Boesecke C; Gey D; Skoutelis ; Goetz M; Phillips AN, 2009, 'Activation and coagulation biomarkers are independent predictors of the development of opportunistic disease in patients with HIV infection', Journal of Infectious Diseases, vol. 200, pp. 973 - 983, http://dx.doi.org/10.1086/605447

Allen K; Guy R; Leslie D; Goller J; Medland N; Roth N; Lewis J; Hellard M, 2008, 'The rise of infectious syphilis in Victoria and the impact of enhanced clinical testing', Australian and New Zealand Journal of Public Health, vol. 32, pp. 38 - 42, http://dx.doi.org/10.1111/j.1753-6405.2008.00164.x

Bodsworth N; Bloch M; McNulty A; Denham I; Doong N; Trottier S; Adena M; Bonney MA; Agnew J; Abdurahman I; Ajam A; Alexander R; Aung A; Barry S; Becker B; Belbin M; Bishop C; Bisshop F; Bourne C; Brett T; Brown K; Butler A; Carmody C; Chan D; Chuah J; Conway D; Daly C; Davies S; Davis C; Davis B; Dever N; Donovan B; Eisen D; Eliades C; Elisha B; Fairley C; Feiglin A; Freeman A; Furner V; Garland S; Genn W; Giannakopoulos J; Glass F; Gold J; Goswami J; Gowers A; Grech J; Hackney P; Hanson B; Hartnell K; Harvey C; Hasan M; Hawkins S; Heley S; Herbst D; Hespe C; Irlicht M; Isaacs A; Katahanas L; Kelly M; Komarowski P; Kostic G; Kozminsky M; Lagios K; Lee D; Lewis P; Liang T; Lyttle H; Mackellar-Michelmore H; Macleod H; Marsh L; Marshall L; McCloskey J; McCurdy D; McEvoy P; McFarlane R; McKeegan P; McMurchie M; McNamee K; Medland N; Menon A; Meyerowitz C; Michaels W; Mobbs M; Montague A; Nicola N; Nurcombe C; O'Connor C; Ooi C; Ostrowskyl O; O'Sullivan M; Owen L; Papp K; Patten J; Panopoulous D; Pell C; Philpot R; Quan D; Quin J; Rhodes D, 2008, '2-Day versus 5-day famciclovir as treatment of recurrences of genital herpes: Results of the FaST study (Sexual Health (2008) 5, 3, (219-225))', Sexual Health, vol. 5, pp. 379, http://dx.doi.org/10.1071/SH08013_CO

Fox Z; Phillips AN; Cohen C; Neuhaus J; Baxter J; Emery S; Hirschel B; Hullsiek K; Stephan C; Lundgren JD, 2008, 'Viral resuppression and detection of drug resistance following interruption of a suppressive non-nucleoside reverse transcriptase inhibitor-based regimen', AIDS, vol. 22, pp. 2279 - 2289, http://dx.doi.org/10.1097/QAD.0b013e328311d16f

Bodsworth NJ; Bloch MT; Mcnulty A; Denham I; Doong N; Trottier S; Adena MA; Bonney M; Agnew J; Australo-Canadian Fast A, 2008, '2-day versus 5-day famciclovir as treatment of recurrences of genital herpes: Results of the FaST study', Sexual Health, vol. 5, pp. 219 - 225, http://dx.doi.org/10.1071/SH08013

Mallon PW; Sedwell R; Rogers GJ; Nolan D; Unemori P; Hoy JF; Samaras K; Kelleher AD; Emery S; Cooper DA; Carr AD, 2008, 'Effect of Rosiglitazone on Peroxisome Proliferator-Activated Receptor gamma Gene Expression in Human Adipose Tissue Is Limited by Antiretroviral Drug-Induced Mitochondrial Dysfunction', Journal of Infectious Diseases, vol. 198, pp. 1794 - 1803, http://dx.doi.org/10.1086/593179

El-Sadr W; Grund B; Neuhaus J; Babiker AG; Cohen C; Darbyshire JH; Emery S; Phillips A; Lundgren JD; Neaton JD, 2008, 'Risk for opportunistic disease and death after reinitiating continuous antiretroviral therapy in patients with HIV previously receiving episodic therapy - a randomized trial', Annals of Internal Medicine, vol. 149, pp. 289 - W62, http://dx.doi.org/10.7326/0003-4819-149-5-200809020-00003

Emery S; Neuhaus J; Phillips A; Babiker AG; Cohen C; Gatell J; Girard P; Grund B; Law MG; Losso MH; Palfreeman A; Wood R, 2008, 'Major clinical outcomes in antiretroviral therapy (ART)-naive participants and in those not receiving ART at baseline in the SMART study', Journal of Infectious Diseases, vol. 197, pp. 1133 - 1144, http://dx.doi.org/10.1086/586713

Lundgren JD; Babiker AG; El-Sadr W; Emery S; Grund B; Neaton JD; Neuhaus J; Phillips A, 2008, 'Inferior clinical outcome of the CD4(+) cell count guided antiretroviral treatment interruption strategy in the SMART study: Role of CD4(+) cell counts and HIV RNA levels during follow-up', Journal of Infectious Diseases, vol. 197, pp. 1145 - 1155, http://dx.doi.org/10.1086/529523

Guy R; Lim MSC; Wang YHJ; Medland N; Anderson J; Roth N; Hellard ME, 2007, 'A new surveillance system for monitoring HIV infection in Victoria, Australia', Sexual Health, vol. 4, pp. 195 - 199, http://dx.doi.org/10.1071/SH07011

Fox Z; Antunes F; Davey R; Gazzard B; Klimas N; Labriola A; Losso M; Neaton JD; Phillips A; Ruxrungtham K; Staszewski S; Weiss L; Lundgren DJ; Aguilar L; Angel EB; Aquilia S; Belloso W; Benetucci J; Bittar V; Cahn P; Casiro A; Contarelli J; Corral J; Daciuk L; David D; Ferrari I; Fridman D; Galache V; Guaragna G; Ivalo S; Laplume H; Lanusse I; Lasala MB; Lattes R; Lasovsky J; Lopardo G; Lourtau L; Lupo S; Maranzana A; Marson C; Massera L; Sanchez MDL; Somenzini C; Tocci M; Algar S; Anderson J; Baker D; Blavius K; Bloch M; Boyle M; Bradford D; Britton P; Carrall L; Carr A; Chuah J; Curry M; D'Arcy-Evans C; Dobson P; Doong N; Egan C; Ferguson W; Finlayson R; French M; Frater A; Gold J; Habel P; Haig K; Holland R; Hyland N; Hoy J; Hudson J; James R; Leung J; Lowe K; MacRae K; McMurchie M; Medland N; Miller S; Murray J; Newman R; David O; Patching J; Primrose R; Ree H; Richardson R; Rogers G; Roney J; Roth N; Sarangapany J; Shaw D; Silberberg C; Skett A; Vale R; Villella C; Walker A; Watson A; Wendt N; Wood H, 2007, 'Predictors of CD4 count change over 8 months of follow up in HIV-1-infected patients with a CD4 count ≥ 300 cells/μL who were assigned to 7.5 MIU interleukin-2', HIV Medicine, vol. 8, pp. 112 - 123, http://dx.doi.org/10.1111/j.1468-1293.2007.00440.x

Pett SL; Wand HC; Law MG; Arduino R; Lopez JC; Knysz B; Pereira L; Pollack S; Reiss P; Tambussi G, 2006, 'Evaluation of subcutaneous proleukin (interleukin-2) in a randomized international trial (ESPRIT): Geographical and gender differences in the baseline characteristics of participants', HIV Clinical Trials, vol. 7, pp. 70 - 85, http://dx.doi.org/10.1310/4733-ACQF-F3P4-2QAC

Fairley CK; Hocking JS; Medland N, 2005, 'Syphilis: Back on the rise, but not unstoppable', Medical Journal of Australia, vol. 183, pp. 172 - 173, http://dx.doi.org/10.5694/j.1326-5377.2005.tb06985.x

Petoumenos K; Ringland C, 2005, 'Antiretroviral treatment change among HIV, hepatitis B virus and hepatitis C virus co-infected patients in the Australian HIV Observational Database', HIV Medicine, vol. 6, pp. 155 - 163, http://dx.doi.org/10.1111/j.1468-1293.2005.00280.x

Ledergerber B; Lundgren JD; Sarah Walker A; Sabin C; Justice A; Reiss P; Mussini C; Wit F; d'Arminio Monforte A; Weber R; Fusco G; Staszewski S; Law M; Hogg R; Lampe F; John Gill M; Castelli F; Phillips AN; Rooney P; Taylor S; Couldwell D; Austin D; Block M; Clemons J; Finlayson R; Petoumenos K; Quan D; Smith D; O'Connor C; Gorton C; Allen D; Mulhall B; Mutimer K; Keeffe N; Cooper D; Carr A; Miller J; Pell C; Ellis D; Baker D; Kidd J; McFarlane R; Liang MT; Brown K; Huffam S; Savage J; Morgan S; Knibbs P; Sowden D; Walker A; Orth D; Lister G; Chuah J; Fankhauser W; Dickson B; Bradford D; Wilson C; Ree H; Magon H; Anderson J; Moore R; Russell D; McGovern G; McNair R; Bal J; Fairley K; Roth N; Eu B; Strecker S; Wood H; Mijch A; Hoy J; Pierce A; McCormack C; Watson K; Medland N; Daye J; Mallal S; French M; Skett J; Maxwel D; Cain A; Montroni M; Scalise G; Costantini A; Giacometti A; Tirelli U; Nasti G; Pastore G; Ladisa N; Perulli ML; Suter F; Arici C; Maggiolo F; Chiodo F; Gritti FM; Colangeli V; Fiorini C; Guerra L; Carosi G, 2004, 'Predictors of trend in CD4-positive T-cell count and mortality among HIV-1-infected individuals with virological failure to all three antiretroviral-drug classes', Lancet, vol. 364, pp. 51 - 62, http://dx.doi.org/10.1016/S0140-6736(04)16589-6

Lister NA; Smith A; Tabrizi S; Hayes P; Medland NA; Garland S; Fairley CK, 2003, 'Screening for Neisseria gonorrhoeae and Chlamydia trachomatis in Men Who Have Sex with Men at Male-only Saunas', Sexually Transmitted Diseases, vol. 30, pp. 886 - 889, http://dx.doi.org/10.1097/01.OLQ.0000099160.26205.22

Lincoln DW; Petoumenos K; Dore GJ, 2003, 'HIV/HBV and HIV/HCV coinfection, and outcomes following highly active antiretroviral therapy', HIV Medicine, vol. 4, pp. 241 - 249, http://dx.doi.org/10.1046/j.1468-1293.2003.00152.x

Baker D; Law MG; Petoumenos K; Smith DE; Anderson JA; Roth N; Mallal SA, 2002, 'Rates of combination antiretroviral treatment change in Australia, 1997-2000', HIV Medicine, vol. 3, pp. 28 - 36, http://dx.doi.org/10.1046/j.1464-2662.2001.00094.x

Medland N, 2001, 'Sexually transmitted diseases in HIV-1-infected patients', LANCET, vol. 357, pp. 1533 - 1534, http://dx.doi.org/10.1016/S0140-6736(00)04693-6

Carr AD; Baker D; Petoumenos K; Law MG; Smith D; Roth N; Anderson JA; Mallal SS, 2001, 'Time trends in antiretroviral treatment use in Australia', Venereology - the Interdisciplinary International Journal of Sexual Health, vol. 14, pp. 162 - 168

Medland NA; Chow EPF; Walker RG; Chen M; Read THR; Fairley CK, 2017, 'Incidence of renal Fanconi syndrome in patients taking antiretroviral therapy including tenofovir disoproxil fumarate', in JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, JOHN WILEY & SONS LTD, Vol. 20, pp. 71 - 71, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000406429800136&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Doyle JS; Bowring AL; Iser DM; Sasadeusz J; Roney J; O'Reilly M; Fairley C; Gane E; Hoy J; Matthews GV; Medland N; Moore R; Prins M; Stoove M; Ban-Kiem T; Hellard ME, 2017, 'Suitability of HCV treatment in primary care settings for individuals with HIV/hepatitis C coinfection', in JOURNAL OF HEPATOLOGY, ELSEVIER SCIENCE BV, NETHERLANDS, Amsterdam, Vol. 66, pp. S524 - S525, presented at International Liver Congress / 52nd Annual Meeting of the European-Association-for-the-Study-of-the-Liver, NETHERLANDS, Amsterdam, 19 April 2017 - 23 April 2017, http://dx.doi.org/10.1016/S0168-8278(17)31450-2

Bowing AL; Doyle JS; Iser DM; Sasadeusz J; Roney J; O'Reilly M; Fairley C; Gane E; Hoy J; Matthews GV; Medland N; Moore R; Prins M; Stoove M; Ban-Kiem T; Hellard ME, 2017, 'High-risk behaviour in a cohort of HIV/hepatitis C coinfected gay and bisexual men commencing hepatitis C treatment', in JOURNAL OF HEPATOLOGY, ELSEVIER SCIENCE BV, NETHERLANDS, Amsterdam, Vol. 66, pp. S269 - S270, presented at International Liver Congress / 52nd Annual Meeting of the European-Association-for-the-Study-of-the-Liver, NETHERLANDS, Amsterdam, 19 April 2017 - 23 April 2017, http://dx.doi.org/10.1016/S0168-8278(17)30852-8